NDCFind

Dalbavancin 00480-3325

Product NDC

00480-3325
Manufacturer
Teva Pharmaceuticals, Inc.
Dosage Form
Injection, Powder, For Solution
Route
Intravenous
Product Type
Human Prescription Drug
Marketing Start
October 29, 2025
Listing Expires
December 31, 2026
Application
ANDA219465
StockMeds — pharmacy-to-pharmacy marketplace

Need to source Dalbavancin? P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

IngredientStrength
Dalbavancin Hydrochloride500 mg/25mL

Drug Class

Lipoglycopeptide Antibacterial [EPC]Lipoglycopeptides [CS]

Packaging Options(1)

1 VIAL in 1 CARTON (0480-3325-01) / 25 mL in 1 VIAL